| 2 | 1/1 | 返回列表 |
| 查看: 882 | 回復(fù): 1 | |||
ananren金蟲 (小有名氣)
|
[交流]
JCR一區(qū)Frontiers in Pharmacology肝病方向?qū)n}邀稿(影響因子5.988) 已有1人參與
|
|
frontiers in pharmacology, jcr藥學(xué)一區(qū)、中科院大類醫(yī)學(xué)二區(qū),小類藥學(xué)二區(qū),影響因子5.988 ,citescore: 6.6 肝病方向?qū)n}:pathophysiology and pharmacological treatments associated with liver failures,https://www.frontiersin.org/rese ... with-liver-failures abstract submission deadline: 30 june 2023, manuscript submission deadline: 02 october 2023 可以與期刊協(xié)商提供相應(yīng)的文章處理費(fèi)豁免,歡迎各位老師同學(xué)投稿! pathophysiology and pharmacological treatments associated with liver failures. about this research topic: acute and chronic liver failures, which represent the loss of liver function, occupy the center stage of hepatic disorders as they are connected with a variety of liver diseases including fatty liver disease, cirrhosis, viral hepatitis, hepatocellular carcinoma and hepatic encephalopathy. the clinical manifestations of liver failures are multifaceted and usually include fatigue, diarrhea, confusion, excess bleeding, and eventually death. in many cases, the only curative treatment option is liver transplantation. although it is generally accepted that liver failures occur under the influence of miscellaneous factors, the detailed molecular mechanisms of various liver failures and associated diseases have not been fully elucidated. since acute and chronic liver failures are major causes of morbidity and mortality globally, a detailed understanding of their associated pathogenesis is essential to improve the treatment options and outcomes in the context of limited liver transplantation. currently, severe toxic, metabolic, viral, and autoimmune injuries are the mainstream theories regarding the causes of acute and chronic liver failures. reducing and limiting the influence of relevant precipitating factors, thus, are the main strategies for the treatment of liver failure-associated disorders. over the last decade, there is also emerging evidence indicating the contribution of aging, mitochondrial damage, cellular senescence, and autophagy inhibition in the development of liver failures. this research topic will try to shed light on novel research elucidating the molecular and cellular pathogenesis of various liver diseases, as well as relevant intervention strategies. the aim is to bring together the latest findings on the pathogenesis mechanisms of liver failure-associated diseases and to propose future treatment strategies for acute and chronic liver failures. the topic editors encourage researchers to submit original researches, brief research reports, systematic reviews, reviews, mini-reviews, and clinical trials relevant to the pathogenesis and management of liver diseases, including, but not limited to the following themes: 1. pathophysiology, pharmacology and intervention strategies of acute and chronic liver failures. 2. pathophysiology, pharmacology and intervention strategies of fatty liver diseases. 3. pathophysiology, pharmacology and intervention strategies of hepatocellular carcinoma. 4. pathophysiology, pharmacology and intervention strategies of liver disease-associated neurological complications. why publish in our research topic? alongside a top group of authors, your work will be published in frontiers in pharmacology, a leading journal in the field with a journal impact factor of 5.988 and a citescore of 6.6. you can read more about the collection here: https://www.frontiersin.org/rese ... with-liver-failures please click the link to register your interest in submitting an article. we accept original researches, brief research reports, systematic reviews, reviews, mini-reviews, and clinical trials. the deadline for submission is 02/10/2023, but frontiers’ fast-track review process, led by my editorial team, means each article is published online as soon as it’s been successfully peer-reviewed and accepted (typically within 61 days). as an open access journal, publishing fees are applied to accepted articles. please contact pharmacology.submissions@frontiersin.org to discuss fees, institutional waivers, and discounts. the team at frontiers will be in touch over the next few days to explain more about contributing to the collection. if you have any other questions in the meantime, please let me know. i believe your insight will be a great addition to this topic, and i look forward to hearing more about your latest research. |
| 2 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 材料工程專碩調(diào)劑自薦信,初試323 +5 | 李白26 2026-03-07 | 5/250 |
|
|---|---|---|---|---|
|
[考研] 一志愿東北大學(xué)080500,英一數(shù)二343分求調(diào)劑 +8 | Seele_v5 2026-03-04 | 8/400 |
|
|
[考研] 0860求調(diào)劑(272分) +3 | lllllcsjsj 2026-03-05 | 3/150 |
|
|
[考研] 327分求調(diào)劑086 +4 | 西紅柿?小帥 2026-03-09 | 7/350 |
|
|
[考研] 265求調(diào)劑 +7 | 小木蟲085600 2026-03-09 | 10/500 |
|
|
[考研] 材料專碩調(diào)劑 +7 | 慕辰123 2026-03-05 | 10/500 |
|
|
[考研] 接受26屆調(diào)劑生 +21 | 豬豬豬毛 2026-03-06 | 21/1050 |
|
|
[考研] 一志愿山東大學(xué),總分327,英語二79,有論文,有競賽,已過四六級(jí) +3 | 木木目目1 2026-03-09 | 3/150 |
|
|
[考研] 0703化學(xué) 學(xué)碩 理工科均可 不區(qū)分研究方向 總分279求調(diào)劑 +9 | 1一11 2026-03-03 | 9/450 |
|
|
[考研] 考研調(diào)劑,一志愿山東大學(xué)材料與化工,328分,政治51 +5 | 關(guān)你西紅柿929 2026-03-08 | 6/300 |
|
|
[考研] 材料工程330分求調(diào)劑,一志愿985 +3 | 小材化本科 2026-03-07 | 3/150 |
|
|
[考研] 269求調(diào)劑 +3 | 朔朔話 2026-03-08 | 4/200 |
|
|
[基金申請(qǐng)] 進(jìn)入個(gè)人成果庫好難,一下午都沒進(jìn)去 +6 | mi_dilee 2026-03-05 | 6/300 |
|
|
[考研] 085701環(huán)境工程317分求調(diào)劑 +9 | 6汆尼9 2026-03-07 | 9/450 |
|
|
[考研] 0307化學(xué)求調(diào)劑 +6 | 0ok0k 2026-03-07 | 6/300 |
|
|
[考研] 070300化學(xué)求調(diào)劑292分 +3 | 打烊eee 2026-03-07 | 3/150 |
|
|
[考研] 材料277分求調(diào)劑 +13 | 飯飯星球 2026-03-04 | 14/700 |
|
|
[考研] 材料與化工304求B區(qū)調(diào)劑 +4 | 邱gl 2026-03-06 | 4/200 |
|
|
[考研] 材料與化工304求調(diào)劑 +7 | 邱gl 2026-03-05 | 10/500 |
|
|
[考研] 322,求調(diào)劑 +3 | 菜菜愛玩 2026-03-04 | 3/150 |
|